Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The Patient Activation Measure: a validation study in a neurological population
School of Occupational Therapy, Dalhousie University, Halifax, Canada; Department of Nursing, Mid Sweden University, Sundsvall, Sweden.
Vise andre og tillknytning
2015 (engelsk)Inngår i: Quality of Life Research, ISSN 0962-9343, E-ISSN 1573-2649, Vol. 24, nr 7, s. 1587-1596Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

PURPOSE: To assess the validity of the Patient Activation Measure (PAM13) of patient activation in persons with neurological conditions.

METHODS: "The Everyday Experience of Living with and Managing a Neurological Condition" (The LINC study) surveyed 948 adults with neurological conditions residing in Canada in 2011 and 2012. Using data for 722 respondents who met coding requirements for the PAM-13, we examined the properties of the measure using principle components analysis, inter-item correlations and Cronbach's alpha to assess unidimensionality and internal consistency. Rasch modeling was used to assess item performance and scaling. Construct validity was assessed by calculating associations between the PAM and known correlates.

RESULTS: PAM-13 provides a suitably reliable and valid instrument for research in patients with neurological conditions, but scaling problems may yield measurement error and biases for those with low levels of activation. This is of particular importance when used in clinical settings or for individual client care. Our study also suggests that measurement of activation may benefit from tailoring items and scaling to specific diagnostic groups such as people with neurological conditions, thus allowing the PAM-13 to recognize unique attributes and management challenges in those conditions.

CONCLUSIONS: The PAM-13 is an internally reliable and valid tool for research purposes. The use of categorical activation "level" in clinical settings should be done with caution.

sted, utgiver, år, opplag, sider
2015. Vol. 24, nr 7, s. 1587-1596
Emneord [en]
Chronic disease management, Measurement Validation, Neurological conditions, Patient activation, PAM-13
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-175634DOI: 10.1007/s11136-014-0908-0ISI: 000356960500003PubMedID: 25557496Scopus ID: 2-s2.0-84933279182OAI: oai:DiVA.org:umu-175634DiVA, id: diva2:1473330
Tilgjengelig fra: 2020-10-06 Laget: 2020-10-06 Sist oppdatert: 2020-10-06bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Audulv, Åsa

Søk i DiVA

Av forfatter/redaktør
Audulv, Åsa
I samme tidsskrift
Quality of Life Research

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 156 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf